| pubmed-article:9636837 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9636837 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
| pubmed-article:9636837 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:9636837 | lifeskim:mentions | umls-concept:C0206417 | lld:lifeskim |
| pubmed-article:9636837 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:9636837 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:9636837 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9636837 | pubmed:dateCreated | 1998-9-10 | lld:pubmed |
| pubmed-article:9636837 | pubmed:abstractText | The most striking of carboplatin's advantages (CBDCA) over cisplatin (CDDP) is its markedly reduced rate of neurotoxic effects. However, the use of CBDCA higher-intensity schedules and the association with other neurotoxic drugs in polychemotherapy may cause some concern about its safety with respect to peripheral nervous system damage. | lld:pubmed |
| pubmed-article:9636837 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9636837 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636837 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9636837 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636837 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9636837 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9636837 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9636837 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:9636837 | pubmed:author | pubmed-author:FrattolaLL | lld:pubmed |
| pubmed-article:9636837 | pubmed:author | pubmed-author:TrediciGG | lld:pubmed |
| pubmed-article:9636837 | pubmed:author | pubmed-author:MinoiaCC | lld:pubmed |
| pubmed-article:9636837 | pubmed:author | pubmed-author:CavalettiGG | lld:pubmed |
| pubmed-article:9636837 | pubmed:author | pubmed-author:FabbricaDD | lld:pubmed |
| pubmed-article:9636837 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9636837 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:9636837 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9636837 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9636837 | pubmed:pagination | 443-7 | lld:pubmed |
| pubmed-article:9636837 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:meshHeading | pubmed-meshheading:9636837-... | lld:pubmed |
| pubmed-article:9636837 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9636837 | pubmed:articleTitle | Carboplatin toxic effects on the peripheral nervous system of the rat. | lld:pubmed |
| pubmed-article:9636837 | pubmed:affiliation | Istituto di Anatomia Umana, Università di Milano, Italy. guido.cavaletti@unimi.it | lld:pubmed |
| pubmed-article:9636837 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9636837 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9636837 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9636837 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9636837 | lld:pubmed |
